申请人:Hoffmann-La Roche Inc.
公开号:US20200308158A1
公开(公告)日:2020-10-01
The invention provides new heterocyclic compounds having the general formula (I)
wherein A, L, X, m, n, R
1
, R
2
and R
3
are as described herein, pharmaceutically acceptable salts thereof, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.